LIPOCINE INC. Equity Method Investment, Ownership Percentage
LIPOCINE INC. (LPCN) had Equity Method Investment, Ownership Percentage of 15.00% as of 2015-11-13, per its 10-Q filed 2021-05-06.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2021-05-06
- 2015-11-13: Equity Method Investment, Ownership Percentage 15.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2015-11-13 | 15.00% 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |